Literature DB >> 19680529

Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.

Michael K Brawer1, Stacy Loeb, Alan W Partin, Naoki Yoshimura, Michael B Chancellor, Claus G Roehrborn, Dean G Assimos, J Curtis Nickel, B Shuch, F Pouliot, Arie S Belldegrun, Ellen Shapiro.   

Abstract

Keywords:  4-Kallikrein panel; Benign prostatic hyperplasia; Benign prostatic specific antigen; Botulinum toxin type A; Enteric urologic surgery; Genitourinary pain index; Hormonal therapy; Inflammation; Laparoscopy for adrenal cortical carcinoma; Lower urinary tract symptoms; Male voiding dysfunction; Nephrolithiasis; Nephron-sparing surgery; Obesity; Partial adrenalectomy; Pediatric urethral stricture; Prostate cancer screening; Roux-en-Y gastric bypass surgery; Silodosin; Stress urinary incontinence; TMPRSS2:ERG; Tumor markers; UPOINT clinical phenotype system; Urethral trauma; Vesicoureteral reflux; Watchful waiting

Year:  2009        PMID： 19680529      PMCID： PMC2725309     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  23 in total

1.  A prospective study of risk factors for nephrolithiasis after Roux-en-Y gastric bypass surgery.

Authors:  Alyssa M Park; Douglas W Storm; Brant R Fulmer; Christopher D Still; G Craig Wood; James E Hartle
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

2.  Prostate specific antigen assay standardization bias could affect clinical decision making.

Authors:  Stacy Loeb; Daniel W Chan; Lori Sokoll; Donghui Kan; Jack Maggiore; Stephen D Mikolajczyk; Dana M Mondo; Chris R Griffin; William J Catalona
Journal:  J Urol       Date:  2008-09-17       Impact factor: 7.450

3.  Obesity, weight gain, and the risk of kidney stones.

Authors:  Eric N Taylor; Meir J Stampfer; Gary C Curhan
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

4.  Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.

Authors:  L Mazzucchelli; P Loetscher; A Kappeler; M Uguccioni; M Baggiolini; J A Laissue; C Mueller
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  The influence of statin medications on prostate-specific antigen levels.

Authors:  Robert J Hamilton; Kenneth C Goldberg; Elizabeth A Platz; Stephen J Freedland
Journal:  J Natl Cancer Inst       Date:  2008-10-28       Impact factor: 13.506

6.  A multicenter comparison of the safety and effectiveness of ureteroscopic laser lithotripsy in obese and normal weight patients.

Authors:  Ben H Chew; Bogard Zavaglia; Ryan F Paterson; Joel M H Teichman; Dirk Lange; Christopher Zappavigna; Brian R Matlaga; Rafael Nunez-Nateras; Aron Bruhn; Hernan O Altamar; Mitchell R Humphreys; Ojas Shah; Nicole L Miller
Journal:  J Endourol       Date:  2013-06       Impact factor: 2.942

Review 7.  Metabolic syndrome and uric acid nephrolithiasis.

Authors:  Khashayar Sakhaee; Naim M Maalouf
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

8.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

9.  Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience.

Authors:  Jean-Jacques Patard; Oleg Shvarts; John S Lam; Allan J Pantuck; Hyung L Kim; Vincenzo Ficarra; Luca Cindolo; Ken-Ryu Han; Alexandre De La Taille; Jacques Tostain; Walter Artibani; Claude C Abbou; Bernard Lobel; Dominique K Chopin; Robert A Figlin; Peter F A Mulders; Arie S Belldegrun
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

10.  Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity.

Authors:  Daniel A Shoskes; J Curtis Nickel; Robert Dolinga; Donna Prots
Journal:  Urology       Date:  2009-01-01       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.